Population pharmacokinetics and exposure-response analysis of durvalumab in combination with gemcitabine and cisplatin in patients with advanced biliary tract cancer

Related articles

1. Individualized Dosing Regimens of Teicoplanin for Patients with Hypoalbuminemia Based on Population Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Parameters

   This article has 10 authors:

   1. Jianpeng He
   2. Chen Ye
   3. Ying Wang
   4. Zhanhua Hu
   5. Zeyuan He
   6. Yuqing Chen
   7. Junyan Wu
   8. Guocheng Li
   9. Min Huang
   10. Xiaoxia Yu

2. Real-world pharmacokinetics of ramucirumab in combination with erlotinib and docetaxel for advanced non-small cell lung cancer: a prospective cohort study

   This article has 17 authors:

   1. Kazumasa Akagi
   2. Shinnosuke Takemoto
   3. Mayu Ohuchi
   4. Shigehiro Yagishita
   5. Ryosuke Ogata
   6. Hiromi Tomono
   7. Noritaka Honda
   8. Yasuhiro Umeyama
   9. Yosuke Dotsu
   10. Midori Matsuo
   11. Hirokazu Taniguchi
   12. Hiroshi Gyotoku
   13. Minoru Fukuda
   14. Hiroshi Soda
   15. Kazuto Ashizawa
   16. Akinobu Hamada
   17. Hiroshi Mukae

3. The efficacy and toxicity of TRT on metastatic NSCLC in patients treated with targeted therapy and chemoimmunotherapy

   This article has 6 authors:

   1. Lishan Xue
   2. Jinquan Yao
   3. Yuxin Geng
   4. Qian Xu
   5. Ning Tang
   6. Feifei Teng